Prevención del cáncer colorectal

von Andreu García, Montserrat, Marzo, Mercè, Mascort, Juanjo, Quintero, Enrique, García-Alfonso, Pilar, López-Ibor, Cristina, Castells, Antoni
Veröffentlicht in Aten Primaria (2009)

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clini...

von Chau, Ian, Fakih, Marwan, García-Alfonso, Pilar, Linke, Zdenĕk, Ruiz Casado, Ana, Marques, Eduardo Polo, Picard, Pascaline, Celanovic, Marina, Cartwright, Thomas
Veröffentlicht in Cancers (Basel) (2020)

Differences in the Therapeutic Approach to Colorectal Cancer in Young and Elderly Patients

von Serra-Rexach, José A., Jimenez, Ana B., García-Alhambra, María A., Pla, Rosa, Vidán, Maite, Rodríguez, Paz, Ortiz, Javier, García-Alfonso, Pilar, Martín, Miguel
Veröffentlicht 2012

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status

von Blagoev, Krastan B., Wilkerson, Julia, Burotto, Mauricio, Kim, Chul, Espinal-Domínguez, Edward, García-Alfonso, Pilar, Alimchandani, Meghna, Miettinen, Markku, Blanco-Codesido, Montserrat, Fojo, Tito
Veröffentlicht in PLoS One (2017)

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades

von Taboada, Alvaro Gregorio Morales, Lominchar, Pablo Lozano, Roman, Lorena Martin, García-Alfonso, Pilar, Martin, Andres Jesús Muñoz, Rodriguez, Jose Antonio Blanco, Pascual, Jose Manuel Asencio
Veröffentlicht in Ann Hepatobiliary Pancreat Surg (2021)

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer

von García-González, Xandra, Cortejoso, Lucía, García, María I., García-Alfonso, Pilar, Robles, Luis, Grávalos, Cristina, González-Haba, Eva, Marta, Pellicer, Sanjurjo, María, López-Fernández, Luis A.
Veröffentlicht in Oncotarget (2015)

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

von García-Alfonso, Pilar, Ferrer, Ana, Gil, Silvia, Dueñas, Rosario, Pérez, María Teresa, Molina, Raquel, Capdevila, Jaume, Safont, María José, Castañón, Carmen, Cano, Juana María, Lara, Ricardo
Veröffentlicht in Target Oncol (2015)

Oral drugs in the treatment of metastatic colorectal cancer

von García-Alfonso, Pilar, Muñoz Martín, Andrés Jesús, Ortega Morán, Laura, Soto Alsar, Javier, Torres Pérez-Solero, Gabriela, Blanco Codesido, Montserrat, Calvo Ferrandiz, Pilar Aitana, Grasso Cicala, Silvina
Veröffentlicht in Ther Adv Med Oncol (2021)

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

von Trojan, Jörg, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, de Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Taylor, Aliki, Kafatos, George, Downey, Gerald, Terwey, Jan-Henrik, van Krieken, J. Han
Veröffentlicht in PLoS One (2015)

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

von Han van Krieken, J., Kafatos, George, Bennett, James, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, De Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Parkar, Parijan, Downey, Gerald, Demonty, Gaston, Trojan, Jörg
Veröffentlicht in BMC Cancer (2017)

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

von García‐Alfonso, Pilar, Benavides, Manuel, Falcó, Esther, Muñoz, Andrés, Gómez, Auxiliadora, Sastre, Javier, Rivera, Fernando, Montagut, Clara, Salgado, Mercedes, López‐Ladrón, Amelia, López, Rafael, Ruiz de Mena, Inmaculada, Durán, Gema, Aranda, Enrique
Veröffentlicht in Oncologist (2018)

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

von Garcia-Alfonso, Pilar, Chaves, Manuel, Muñoz, Andrés, Salud, Antonieta, García-Gonzalez, Maria, Grávalos, Cristina, Massuti, Bartomeu, González-Flores, Encarna, Queralt, Bernardo, López-Ladrón, Amelia, Losa, Ferran, Gómez, Maria Jose, Oltra, Amparo, Aranda, Enrique
Veröffentlicht in BMC Cancer (2015)

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

von Fogelman, David, Cubillo, Antonio, García‐Alfonso, Pilar, Mirón, María Luisa Limón, Nemunaitis, John, Flora, Daniel, Borg, Christophe, Mineur, Laurent, Vieitez, Jose M., Cohn, Allen, Saylors, Gene, Assad, Albert, Switzky, Julie, Zhou, Li, Bendell, Johanna
Veröffentlicht in Cancer Med (2018)

Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyse...

von Grothey, Axel, Yoshino, Takayuki, Bodoky, Gyorgy, Ciuleanu, Tudor, Garcia-Carbonero, Rocio, García-Alfonso, Pilar, Van Cutsem, Eric, Muro, Kei, Mytelka, Daniel S, Li, Li, Lipkovich, Olga, Hsu, Yanzhi, Sashegyi, Andreas, Ferry, David, Nasroulah, Federico, Tabernero, Josep
Veröffentlicht in ESMO Open (2018)

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

von Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez Fernandez, Elena, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
Veröffentlicht in Br J Cancer (2018)

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

von Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Gracian, Antonio Cubillo, Mangel, Laszlo, Fernandez, Elena Elez, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
Veröffentlicht in Br J Cancer (2019)

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-secti...

von Capdevila, Jaume, Sevilla, Isabel, Alonso, Vicente, Antón Aparicio, Luís, Jiménez Fonseca, Paula, Grande, Enrique, Reina, Juan José, Manzano, José Luís, Alonso Lájara, Juan Domingo, Barriuso, Jorge, Castellano, Daniel, Medina, Javier, López, Carlos, Segura, Ángel, Carrera, Sergio, Crespo, Guillermo, Fuster, José, Munarriz, Javier, García Alfonso, Pilar
Veröffentlicht in BMC Cancer (2015)

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

von Benavides, Manuel, Díaz-Rubio, Eduardo, Carrato, Alfredo, Abad, Albert, Guillén, Carmen, Garcia-Alfonso, Pilar, Gil, Silvia, Cano, María Teresa, Safont, María José, Gravalos, Cristina, Manzano, José Luis, Sánchez, Antonio, Alcaide, Julia, López, Rafael, Massutí, Bartomeu, Sastre, Javier, Martínez, Eva, Escudero, Pilar, Méndez, Miguel, Aranda, Enrique
Veröffentlicht in ESMO Open (2019)

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the...

von Tabernero, Josep, Grothey, Axel, Van Cutsem, Eric, Yaeger, Rona, Wasan, Harpreet, Yoshino, Takayuki, Desai, Jayesh, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod Kyrre, Arkenau, Hendrik-Tobias, Garcia-Alfonso, Pilar, Elez, Elena, Gollerkeri, Ashwin, Maharry, Kati, Christy-Bittel, Janna, Kopetz, Scott
Veröffentlicht in J Clin Oncol (2021)

VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)

von Feliu, Jaime, Garcia‐Carbonero, Rocio, Capdevila, Jaume, Guasch, Inmaculada, Alonso‐Orduna, Vicente, Lopez, Carlos, Garcia‐Alfonso, Pilar, Castanon, Carmen, Sevilla, Isabel, Cerezo, Laura, Conill, Carles, Quintana‐Angel, Begona, Sanchez, Maria E., Ghanem, Ismael, Martin‐Richard, Marta, Lopez‐Gomez, Miriam, Leon, Ana, Caro, Monica, Fernandez, Teresa, Maurel, Joan
Veröffentlicht in Cancer Med (2019)